Regenicin Inc (RGIN) - Medical Equipment - Deals and Alliances Profile
[Updated: 23-10-2018]

Published by Global Data on 23rd October 2018 | Ref: 1085984 | This Report Is In Stock

$250 | Single User
$500 | Site License
$750 | Enterprise License
$250 | Single User
$500 | Site License
$750 | Enterprise License

Introduction

Summary

Regenicin Inc (Regenicin), formerly Windstar Inc is a biotechnology company that develops regenerative cell therapies. The company offers NovaDerm, a tissue-engineered skin prepared from autologous skin cells. Its NovaDerm technology uses the patient’s own skin cells to generate living, tissue-engineered skin for the treatment of severe burns. Regenicin offers banked allogenic cell products for treatment of chronic wounds, cosmetic and other topical testing, and medical testing services. The company develops products for diabetes and chronic wounds including ulcers, adult stem cell therapies and reconstructive surgical applications. It has operations throughout the US. Regenicin is headquartered in Little Falls, New Jersey, the US.

Regenicin Inc (RGIN) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Regenicin Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Regenicin Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Regenicin Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Regenicin Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Regenicin Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Regenicin Inc, Medical Equipment, Deal Details 10

Debt Offering 10

Regenicin Raises USD0.1 Million in Private Placement of 8% Note Due May 2014 10

Regenicin Raises USD0.3 Million in Private Placement of 8% Notes Due 2014 11

Regenicin Raises Funds through Private Placement of 8% Note Due November 2013 12

Regenicin Raises USD0.1 Million in Private Placement of 10% Note Due June 2013 13

Regenicin Raises USD0.1 Million in Private Placement of 10% Note Due January 2013 14

Regenicin Raises Funds through Private Placement of 33% Note Due October 2012 15

Regenicin Raises USD0.2 Million in Private Placement of 33% Note Due November 2012 16

Regenicin Raises USD0.2 Million in Private Placement of 33% Note Due 2012 17

Regenicin Raises USD0.1 Million in Private Placement of 8% Note Due March 2012 18

Regenicin Raises USD0.16 Million in Private Placement of 5% Note Due June 2012 19

Regenicin Inc - Key Competitors 20

Regenicin Inc - Key Employees 21

Regenicin Inc - Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 23

Financial Announcements 23

Jan 18, 2017: Regenicin Reports 2016 Operating Results, Outlines Milestones for 2017 23

Appendix 24

Methodology 24

About GlobalData 24

Contact Us 24

Disclaimer 24

Additional Details

Publisher

Global Data

Publisher Information

Reference

1085984 | GDME272991D

Number of Pages

24

Report Format

PDF

This report is published by Global Data

Download Free Report Summary PDF

Regenicin Inc (RGIN) - Medical Equipment - Deals and Alliances Profile [Updated: 23-10-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.